Explore how hybridization capture solutions are revolutionizing circulating tumor DNA (ctDNA) research for minimal residual disease (MRD) in this 17-minute webinar by Integrated DNA Technologies (IDT). Gain valuable insights into the significance of MRD research, its advantages over traditional methods, and its role in discovering new biomarkers. Understand how IDT's technology is helping researchers overcome challenges in ctDNA analysis for resected cancer samples. Discover the potential for new collaborations and breakthroughs in oncology research as these innovative studies are brought to the forefront. For more information, visit https://idtb.io/bmru7r.
ctDNA for Minimal Disease Research by Hybridization Capture in Resected Cancer Samples
Integrated DNA Technologies (IDT) via YouTube
Overview
Syllabus
ctDNA for minimal disease research by hybridization capture in resected cancer samples
Taught by
Integrated DNA Technologies (IDT)
Related Courses
-
Overcome Challenges in Cancer Research with xGen NGS Solutions for Oncology and MRD Research
-
Enumeration and Molecular Profiling of Circulating Tumor Cells for Diagnosis and Therapeutic Monitoring of Metastatic Cancer
-
Unlocking the Potential of Ultra-Low Frequency Variant Identification for Cancer Research
-
Circulating Tumor HPV DNA Testing for HPV-Positive Head and Neck Cancer
-
Emerging Solutions for Non-Invasive Cancer Monitoring
